These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16871480)

  • 21. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Microglia in Psychostimulant Addiction.
    da Silva MCM; Iglesias LP; Candelario-Jalil E; Khoshbouei H; Moreira FA; de Oliveira ACP
    Curr Neuropharmacol; 2023; 21(2):235-259. PubMed ID: 36503452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction.
    Zaniewska M; Filip M; Przegalinski E
    Curr Neuropharmacol; 2015; 13(3):407-18. PubMed ID: 26411968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of dopamine in drug dependence processes].
    Tassin JP
    Bull Acad Natl Med; 2002; 186(2):295-304; discussion 304-5. PubMed ID: 12145837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.
    Svetlov SI; Kobeissy FH; Gold MS
    J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology.
    Donovan JL; DeVane CL
    Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine mechanisms of cocaine addiction.
    Kiyatkin EA
    Int J Neurosci; 1994 Sep; 78(1-2):75-101. PubMed ID: 7829294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitter transporters as molecular targets for addictive drugs.
    Amara SG; Sonders MS
    Drug Alcohol Depend; 1998; 51(1-2):87-96. PubMed ID: 9716932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Janus face of caffeine.
    Porciúncula LO; Sallaberry C; Mioranzza S; Botton PH; Rosemberg DB
    Neurochem Int; 2013 Nov; 63(6):594-609. PubMed ID: 24055856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Caffeine, the most frequently consumed psychostimulant: a narrative review article].
    Gahr M
    Fortschr Neurol Psychiatr; 2020 May; 88(5):318-330. PubMed ID: 31610604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine receptor agonists, partial agonists and psychostimulant addiction.
    Pulvirenti L; Koob GF
    Trends Pharmacol Sci; 1994 Oct; 15(10):374-9. PubMed ID: 7809953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.
    Steiner H; Van Waes V
    Prog Neurobiol; 2013 Jan; 100():60-80. PubMed ID: 23085425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychostimulants: Basic and Clinical Pharmacology.
    McCreary AC; Müller CP; Filip M
    Int Rev Neurobiol; 2015; 120():41-83. PubMed ID: 26070753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.
    Ferré S
    Psychopharmacology (Berl); 2016 May; 233(10):1963-79. PubMed ID: 26786412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between sleep and addiction: the role of drug-environment conditioning.
    Berro LF; Frussa-Filho R; Tufik S; Andersen ML
    Med Hypotheses; 2014 Mar; 82(3):374-6. PubMed ID: 24468577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of impulsivity in psychostimulant- and stress-induced dopamine release: Review of human imaging studies.
    Bosker WM; Neuner I; Shah NJ
    Neurosci Biobehav Rev; 2017 Jul; 78():82-90. PubMed ID: 28438467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs of abuse and immediate-early genes in the forebrain.
    Harlan RE; Garcia MM
    Mol Neurobiol; 1998 Jun; 16(3):221-67. PubMed ID: 9626665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular biology of addictive drugs.
    Mackler SA; Eberwine JH
    Mol Neurobiol; 1991; 5(1):45-58. PubMed ID: 1725703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arresting the Development of Addiction: The Role of
    Porter-Stransky KA; Weinshenker D
    J Pharmacol Exp Ther; 2017 Jun; 361(3):341-348. PubMed ID: 28302862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.